May 2017
News
In this issue
| Continuity of Therapy Access for Genvoya and Descovy |
|
| Restricted Benefit for Chloramphenicol |
|
| PBS changes effective May 2017 |
|
| Running the monthly update for Fred Dispense |
|
Continuity of Therapy Access for Genvoya and Descovy
The PBS has advised they will honour scripts written prior to 1 May 2017, for a period of 12 months, for the following deleted items:
- 10680D Genvoya 10mg/200mg/150mg/150mg Tablets
- 10946D Descovy 200mg/10mg Tablets
- 10966E Descovy 200mg/25mg Tablets
Restricted Benefit for Chloramphenicol
Pharmacists are advised to make note that the new item listing of 11112W chloramphenicol eye drops is a restricted benefit for patients identifying as Aboriginal or Torres Strait Islander.
Fred Help Centre featured articles and documents
Matching Drugs between Fred Office and Fred Dispense
For accurate stock-on-hand and sales information, your drug items must be correctly matched between Fred Office and Fred Dispense. Incorrect linking will impact your usage information and prevent accurate ordering and reporting.
The Fred Office Drug Matching User Guide explains how to:
- Review unmatched drugs with the Unmatched Script report.
- Match unmatched drugs to Fred Office items.
- Perform a stock adjustment to correct your SOH levels.
If your pharmacy has recently converted to Fred Office, we recommend that you follow the procedures in this document every day for the first two weeks. After you have been using Fred Office for two weeks, follow the procedures in this document once per week, to help ensure that your dispensing correctly tracks your POS data.
Download the Fred Office Drug Matching User Guide from the Fred Help Centre
PBS changes effective May 2017
For the full Schedule of Pharmaceutical Benefits, go to the PBS website at http://www.pbs.gov.au/ where you can search the schedule by drug name.
For your convenience, we've also uploaded a printable summary of this month's important PBS changes to this site: